Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US seeks to ensure accuracy of anthrax diagnostics

This article was originally published in Clinica

Executive Summary

US federal health officials grappling with anthrax attacks in the US have become increasingly sceptical about the usefulness of many of the tests being used to detect the bacteria. Last week, for example, the Centers for Disease Control and Prevention (CDC) advised clinicians not to order prophylactic treatments for persons at risk of exposure to anthrax solely on the basis of an environmental test.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT074037

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel